Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.
Press releases published on July 21, 2025
Cologix conclut une titrisation adossée à des actifs de 525 millions de dollars américains pour soutenir l’infrastructure, l’interconnexion et la croissance de l’IA
GlobeNewswire
·
July 21, 2025
DENVER, 21 juill. 2025 (GLOBE NEWSWIRE) -- Cologix, le chef de file nord-américain d’interconnexions neutres et des centres de données hyperscale edge, a annoncé aujourd’hui qu’elle a conclu une titrisation, adossée à des actifs sécurisés (ABS), de 525 …
Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease
GlobeNewswire
·
July 21, 2025
Longeveron has licensed issued US Patent 12,168,028 B2, entitled “Methods for obtaining cardiomyogenic precursor cells” from the University of Miami New patent protects a method to derive GHRH-Receptor+ cardiomyogenic cells from pluripotent stem cells ( …
ONAR Appoints Former MDC Partners Chairman & CEO Scott Kauffman to Lead Board, Signaling Aggressive Growth Strategy
GlobeNewswire
·
July 21, 2025
Miami, FL, July 21, 2025 (GLOBE NEWSWIRE) -- ONAR Holding Corporation (OTCQB: ONAR), a fast-growing marketing technology company and global network of performance-driven agencies, today announced the appointment of Scott Kauffman, former Chairman and CEO …
CentralReach Adds Workforce Management System Viventium to Preferred Partnership Network
GlobeNewswire
·
July 21, 2025
Fort Lauderdale, FL, July 21, 2025 (GLOBE NEWSWIRE) -- CentralReach, a leading provider of Autism and IDD Care software for ABA, multidisciplinary, and special education, today announced a new preferred partnership with Viventium, an industry-leading …
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Class A Ordinary Shares of GigaCloud Technology Inc – GCT
GlobeNewswire
·
July 21, 2025
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP and The Rosen Law Firm, P.A. announce that the United States District Court for the Southern District of New York has approved the following announcement of a proposed class action settlement that …
Edge Conversion Launches Custom AI Systems to Supercharge Sales and Scale Growth for Small Businesses
GlobeNewswire
·
July 21, 2025
Los Angeles, California, July 21, 2025 (GLOBE NEWSWIRE) -- Edge Conversion, an emerging AI automation agency based in Los Angeles, has unveiled a suite of tailored AI systems that simplify operations and supercharge growth for service-based and online …
FloQast Named to CNBC’s 2025 List of World’s Top Fintech Companies in Enterprise Category
GlobeNewswire
·
July 21, 2025
LOS ANGELES, July 21, 2025 (GLOBE NEWSWIRE) -- FloQast, an Accounting Transformation Platform created by accountants for accountants, today announced it has been named to CNBC’s 2025 list of the World’s Top Fintech Companies, securing a spot in the …
Sharecare introduces Condition Masterclass to support patient education and health literacy for chronic disease management
GlobeNewswire
·
July 21, 2025
ATLANTA, July 21, 2025 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced a new patient education destination that empowers …
Spirair Receives FDA Clearance for TurbAlign, a New Bioabsorbable Implant That Helps Keep Nasal Passages Open After Sinus Surgery
GlobeNewswire
·
July 21, 2025
SOUTH SAN FRANCISCO, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Spirair, Inc., an early-stage medical device company developing minimally invasive solutions to help otolaryngologists (ENTs) improve patient care, today announced that the U.S. Food and Drug …
Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq
GlobeNewswire
·
July 21, 2025
SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today …
Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum
GlobeNewswire
·
July 21, 2025
SOUTH SAN FRANCISCO, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
Lakeland Fire + Safety Announces Closure of Hull, UK and Quitman, Arkansas Facilities as Part of Strategic Consolidation Plan
GlobeNewswire
·
July 21, 2025
$1 Million Savings Included in $4 Million Total Annual Cost Reduction Initiatives to Streamline Global Operations and Improve Profitability HUNTSVILLE, Ala., July 21, 2025 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland …
Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors
GlobeNewswire
·
July 21, 2025
- New board members bring decades of experience in company building, corporate strategy, commercialization, and business development CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company …
Bit Origin Acquires Over 40 Million Dogecoin (DOGE) to Advance Treasury Strategy
GlobeNewswire
·
July 21, 2025
SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) ("Bit Origin" or the "Company"), today announced the initial purchase of approximately 40.5 million DOGE. This represents the first strategic acquisition under the Company's digital …
Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025
GlobeNewswire
·
July 21, 2025
Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025 Gdańsk, Poland - July 21, 2025 - Urteste S.A. (Warsaw Stock Exchange: URT), a company specializing in the development of innovative technology for cancer …
Arbe to Announce Second Quarter 2025 Financial Results and to Hold a Conference Call on August 7, 2025
GlobeNewswire
·
July 21, 2025
Tel Aviv, Israel, July 21, 2025 — Arbe Robotics Ltd. (Nasdaq, TASE: ARBE), a global leader in perception radar solutions, today announced that it will hold its second quarter 2025 conference call on Thursday, August 7, 2025 at 8:30 a.m. Eastern Time. The …
ASML reports transactions under its current share buyback program
GlobeNewswire
·
July 21, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
July 21, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from July 14, 2025 to July 18, 2025 AMSTERDAM – July 21, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …
UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI™ in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire
·
July 21, 2025
Findings published in the journal of Clinical Genitourinary Cancer show patients remained event-free for a median of two years after achieving complete response with ZUSDURI (mitomycin) intravesical solution. Among the 17 patients who achieved complete …
NKGen Receives FDA Expanded Access Protocol Authorization for Landmark Treatment of Several Neurodegenerative Diseases
GlobeNewswire
·
July 21, 2025
Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in Alzheimer’s Disease. Company receives expanded access …